30 January 2025

---

Henry Schein to Announce Q4 and Full-Year 2024 Results on February 25, 2025

---

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, recently announced that it will release its fourth-quarter and full-year 2024 financial results before the stock market opens on Tuesday, February 25, 2025.

The company will also provide a live webcast of its earnings conference call on the same day, beginning at 8:00 AM Eastern Time.

Speakers on the call will include Stanley M. Bergman, chairman of the board and CEO of Henry Schein, and Ronald N. South, senior vice president and chief financial officer.

Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay will be available on the Henry Schein website following the presentation.

Cautionary Note Regarding Forward-Looking Statements

In accordance with the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary remarks regarding important factors that could cause future results to differ materially from the forward-looking statements, expectations, and assumptions expressed or implied herein. All forward-looking statements made by us are subject to risks and uncertainties and are not guarantees of future performance. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, and achievements—or industry results—to differ materially from any future results, performance, or achievements expressed or implied by such forward-looking statements. These statements include EPS and Adjusted EBITDA guidance and are generally identified by the use of terms such as “may,” “could,” “expect,” “intend,” “believe,” “plan,” “estimate,” “forecast,” “project,” “anticipate,” or other comparable terms.

A fuller discussion of our operations, financial condition, and status of litigation matters, including factors that may affect our business and future prospects, is contained in documents we have filed with the United States Securities and Exchange Commission (SEC), including our Annual Report on Form 10-K, and will be included in subsequent periodic filings. These documents identify important risk factors that could cause our actual performance to differ materially from current expectations.

Risk factors and uncertainties that could cause actual results to differ materially include, but are not limited to:

Dependence on third parties for the manufacture and supply of products.

Challenges with developing or acquiring new products (particularly technology products) that achieve market acceptance with acceptable margins.

Transitional challenges from acquisitions, dispositions, and joint ventures, including failure to achieve anticipated synergies or benefits.

Security risks associated with information systems and technology products, including cyberattacks or data security breaches (such as the October 2023 incident).

Changes in the healthcare industry or customer purchasing power.

Macroeconomic and political conditions, including inflation, deflation, wars, and fluctuations in energy pricing.

Failure to comply with regulatory requirements.

Risks related to disease outbreaks, epidemics, and pandemics (e.g., COVID-19).

Litigation risks and new or unanticipated developments in existing litigation.

We caution that these factors are not exhaustive and many are beyond our control. Forward-looking statements should not be relied upon as predictions of actual results. We undertake no duty to update forward-looking statements except as required by law.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for healthcare professionals powered by a network of people and technology. With approximately 26,000 Team Schein Members worldwide, the company’s trusted advisors provide more than 1 million customers globally with over 300 valued solutions to improve operational success and clinical outcomes.

These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, offering more than 300,000 branded products and Henry Schein corporate brand products.

A FORTUNE 500 company and a member of the S&P 500 index, Henry Schein is headquartered in Melville, N.Y., and operates in 33 countries and territories. The company’s 2023 sales reached $12.3 billion, growing at a compound annual rate of approximately 11.5 percent since becoming a public company in 1995.

Source: www.henryschein.com